Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pavlakis

Showing results (71-80 of 294) with videos related to

Pageof 30
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 1, 1982
Properties of human growth hormone polypeptides: purified from pituitary extracts and synthesized in monkey kidney cells and bacteriaN Hizuka, C M Hendricks, G N Pavlakis, et al.
Oncology Reports|June 20, 2012
A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancerM Michael, N Pavlakis, P Clingan, et al.
Cancer|February 19, 2000
The predictive value of body protein for chemotherapy-induced toxicityA Aslani, R C Smith, B J Allen, et al.
Journal of Virology|September 1, 1996
The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its functionC Tabernero, A S Zolotukhin, A Valentin, et al.
Breast Cancer Research and Treatment|January 5, 2000
Changes in body composition during breast cancer chemotherapy with the CMF-regimenA Aslani, R C Smith, B J Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNAB K Felber, M Hadzopoulou-Cladaras, C Cladaras, et al.
Cancers|March 6, 2021
Heterodimeric IL-15 in Cancer ImmunotherapyCristina Bergamaschi, Vasiliki Stravokefalou, Dimitris Stellas, et al.
The EMBO Journal|January 31, 1998
Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulationM E Greenberg, S Bronson, M Lock, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNAT Unge, L Solomin, M Mellini, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR traffickingT Kino, R H Stauber, J H Resau, et al.
Pageof 30

Showing results (71-80 of 294) with videos related to

Sort By:
Pageof 30
The Journal of Clinical Endocrinology and Metabolism|September 1, 1982
Properties of human growth hormone polypeptides: purified from pituitary extracts and synthesized in monkey kidney cells and bacteriaN Hizuka, C M Hendricks, G N Pavlakis, et al.
Oncology Reports|June 20, 2012
A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancerM Michael, N Pavlakis, P Clingan, et al.
Cancer|February 19, 2000
The predictive value of body protein for chemotherapy-induced toxicityA Aslani, R C Smith, B J Allen, et al.
Journal of Virology|September 1, 1996
The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its functionC Tabernero, A S Zolotukhin, A Valentin, et al.
Breast Cancer Research and Treatment|January 5, 2000
Changes in body composition during breast cancer chemotherapy with the CMF-regimenA Aslani, R C Smith, B J Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNAB K Felber, M Hadzopoulou-Cladaras, C Cladaras, et al.
Cancers|March 6, 2021
Heterodimeric IL-15 in Cancer ImmunotherapyCristina Bergamaschi, Vasiliki Stravokefalou, Dimitris Stellas, et al.
The EMBO Journal|January 31, 1998
Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulationM E Greenberg, S Bronson, M Lock, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNAT Unge, L Solomin, M Mellini, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR traffickingT Kino, R H Stauber, J H Resau, et al.
Pageof 30